NEW YORK (GenomeWeb) – Agilent Technologies announced today that it has signed a co-marketing agreement with Carlsbad, California-based Applied Spectral Imaging for fluorescent in situ hybridization (FISH) products.

Under the terms of the agreement, the firms will jointly market ASI's GenASIs imaging platforms with Agilent's FISH products, including the Dako Omnis instrument for automated sample processing. The agreement would provide pathology labs with the components to create a fully automated, end-to-end FISH workflow, the firms said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.